SYRE
#1070
Spyre Therapeutics, Inc. - Common Stock
87.2 5 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.23%
Changement Mensuel
-16.86%
Evolution sur 6 mois
+116.29%
Changement Annuel
+264.91%
Clôture Précédente
87.0 5
Open
87.2 5
Low
87.2 5
High
87.2 5
Volume
131
Financials
- Market Capitalization 7.69 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-44.84
ratio cours/chiffre d'affaires
411.15
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | 0.00% | +0.09% | +0.65% | +152.04% | 8.40 B USD | ||
| 1047 |  IMVT Immunovant, Inc. - Common Stock | 39.12 USD | -0.94% | -9.59% | -1.54% | +103.64% | 8.08 B USD | ||
| 1097 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 104.89 USD | -0.50% | -4.83% | -5.36% | -4.91% | 7.22 B USD | ||
| 1133 |  SRRK Scholar Rock Holding Corporation - Common Stock | 55.94 USD | -0.29% | -4.78% | +16.37% | +86.34% | 6.81 B USD |